A network of RNA and protein interactions in fronto temporal dementia

Frontiers in Molecular Neuroscience

Volumn 8, Issue MAR, 2015, Pages

  Fontana, Francesca ^a   Siva, Kavitha ^a   Denti, Michela A ^a,b  

^a UNIVERSITY OF TRENTO   (Italy)

^b CNR   (Italy)

Author keywords

C9ORF72; CHMP2B; FTD; FUS; Progranulin; Tau; TDP 43

Indexed keywords

ARGONAUTE 2 PROTEIN; CHARGED MULTIVESICULAR BODY PROTEIN; FUSED IN SARCOMA PROTEIN; MICRORNA; MICROTUBULE ASSOCIATED PROTEIN; NEUREXIN; PEPTIDES AND PROTEINS; PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

AUTOPHAGOSOME; CHROMOSOME 9 OPEN READING FRAME 72 GENE; DOWN REGULATION; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1 GENE; PATHOGENESIS; POLYADENYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; REVIEW; RNA PROCESSING; RNA SPLICING; UPREGULATION;

EID: 84927725602     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00009     Document Type: Review

References (343)

1. Ahmed, Z., Mackenzie, I. R., Hutton, M. L., and Dickson, D. W. (2007). Progranulin in frontotemporal lobar degeneration and neuroinflammation. J. Neuroinflammation 4:7. doi: 10.1186/1742-2094-4-7
2. Almeida, S., Zhou, L., and Gao, F.-B. (2011). Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins. PLoS ONE 6:e26454. doi: 10.1371/journal.pone.0026454
3. Anderson, P., and Kedersha, N. (2008). Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 33, 141-150. doi: 10.1016/j.tibs.2007.12.003
4. Anfossi, M., Vuono, R., Maletta, R., Virdee, K., Mirabelli, M., Colao, R., et al. (2011). Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia. Neurobiol. Aging 32, 757.e1-757.e11. doi: 10.1016/j.neurobiolaging.2010.12.013
5. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611. doi: 10.1016/j.bbrc.2006.10.093
6. Arriagada, P. V., Marzloff, K., and Hyman, B. T. (1992). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681-1688. doi: 10.1212/WNL.42.9.1681
7. Ash, P. E., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., Dejesus-Hernandez, M., et al. (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639-646. doi: 10.1016/j.neuron.2013.02.004
8. Avendaño-Vázquez, S. E., Dhir, A., Bembich, S., Buratti, E., Proudfoot, N., and Baralle, F. (2012). Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev. 26, 1679-1684. doi: 10.1101/gad.194829.112
9. Ayala, Y. M., Pantano, S., D'Ambrogio, A., Buratti, E., Brindisi, A., Marchetti, C., et al. (2005). Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348, 575-588. doi: 10.1016/j.jmb.2005.02.038
10. Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., et al. (2006). Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916-919. doi: 10.1038/nature05016
11. Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., and Wu, J. Y. (2010). Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial ALS 30. J. Neurosci. 30, 639-649. doi: 10.1523/JNEUROSCI.4988-09.2010
12. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233. doi: 10.1016/j.cell.2009.01.002
13. Bartolome, F., Wu, H.-C., Burchell, V. S., Preza, E., Wray, S., Mahoney, C. J., et al. (2013). Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 78, 57-64. doi: 10.1016/j.neuron.2013.02.028
14. Bateman, A., and Bennett, H. P. (2009). The granulin gene family: from cancer to dementia. Bioessays 31, 1245-1254. doi: 10.1002/bies.200900086
15. Belly, A., Moreau-Gachelin, F., Sadoul, R., and Goldberg, Y. (2005). Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci. Lett. 379, 152-157. doi: 10.1016/j.neulet.2004.12.071
16. Belzil, V. V., Gendron, T. F., and Petrucelli, L. (2013). RNA-mediated toxicity in neurodegenerative disease. Mol. Cell. Neurosci. 56, 406-419. doi: 10.1016/j.mcn.2012.12.006
17. Benajiba, L., Le Ber, I., Camuzat, A., Lacoste, M., Thomas-Anterion, C., Couratier, P., et al. (2009). TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 65, 470-473. doi: 10.1002/ana.21612
18. Bernardi, L., Frangipane, F., Smirne, N., Colao, R., Puccio, G., Curcio, S. M., et al. (2012). Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy. Neurobiol. Aging 33, 2948.e1-2948.e10. doi: 10.1016/j.neurobiolaging.2012.06.017
19. Bernstein, E., Caudy, A. A., Hammond, S. M., and Hannon, G. J. (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366. doi: 10.1038/35053110
20. Bersano, A., Del Bo, R., Lamperti, C., Ghezzi, S., Fagiolari, G., Fortunato, F., et al. (2009). Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging 30, 752-758. doi: 10.1016/j.neurobiolaging.2007.08.009
21. Bertolotti, A., Lutz, Y., and Heard, D. (1996). hTAF (II) 68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15, 5022-5031.
22. Bessi, V., Bagnoli, S., Nacmias, B., Tedde, A., Sorbi, S., and Bracco, L. (2010). Semantic dementia associated with mutation V363I in the tau gene. J. Neurol. Sci. 296, 112-114. doi: 10.1016/j.jns.2010.06.007
23. Bhandari, V., Daniel, R., Lim, P. S., and Bateman, A. (1996). Structural and functional analysis of a promoter of the human granulin/epithelin gene. Biochem. J. 319(Pt 2), 441-447.
24. Binder, L. I., Frankfurter, A., and Rebhun, L. I. (1985). The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378. doi: 10.1083/jcb.101.4.1371
25. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigó, R., Gingeras, T. R., and Margulies, E. H. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816. doi: 10.1038/nature05874
26. Bodon, G., Chassefeyre, R., Pernet-Gallay, K., Martinelli, N., Effantin, G., Hulsik, D. L., et al. (2011). Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane. J. Biol. Chem. 286, 40276-40286. doi: 10.1074/jbc.M111.283671
27. Bond, A. M., Vangompel, M. J., Sametsky, E. A., Clark, M. F., Savage, J. C., Disterhoft, J. F., et al. (2009). Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat. Neurosci. 12, 1020-1027. doi: 10.1038/nn.2371
28. Borroni, B., Archetti, S., Alberici, A., Agosti, C., Gennarelli, M., Bigni, B., et al. (2008). Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics 9, 197-205. doi: 10.1007/s10048-008-0127-3
29. Borroni, B., Bonvicini, C., Alberici, A., Buratti, E., Agosti, C., Archetti, S., et al. (2009). Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 30, E974-E983. doi: 10.1002/humu.21100
30. Bosco, D. A., Lemay, N., Ko, H. K., Zhou, H., Burke, C., Kwiatkowski, T. J., et al. (2010). Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 19, 4160-4175. doi: 10.1093/hmg/ddq335
31. Bottos, A., Rissone, A., Bussolino, F., and Arese, M. (2011). Neurexins and neuroligins: synapses look out of the nervous system. Cell. Mol. Life Sci. 68, 2655-2666. doi: 10.1007/s00018-011-0664-z
32. Broe, M., Kril, J., and Halliday, G. M. (2004). Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127, 2214-2220. doi: 10.1093/brain/awh250
33. Bronfman, F. C., Escudero, C. A., and Weis, J. K. A. (2007). Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 67, 1183-1203. doi: 10.1002/dneu.20513
34. Bronner, I. F., Rizzu, P., Seelaar, H., van Mil, S. E., Anar, B., Azmani, A., et al. (2007). Progranulin mutations in Dutch familial frontotemporal lobar degeneration. Eur. J. Hum. Genet. 15, 369-374. doi: 10.1038/sj.ejhg.5201772
35. Broustal, O., Camuzat, A., Guillot-Noël, L., Guy, N., Millecamps, S., Deffond, D., et al. (2010). FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J. Alzheimers Dis. 22, 765-769.
36. Brown, J., Lantos, P. L., Roques, P., Fidani, L., and Rossor, M. N. (1996). Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study. J. Neurol. Sci. 135, 21-30. doi: 10.1016/0022-510X(95)00236-U
37. Buchan, J. R., Kolaitis, R.-M., Taylor, J. P., and Parker, R. (2013). Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461-1474. doi: 10.1016/j.cell.2013.05.037
38. Buchan, J. R., and Parker, R. (2009). Eukaryotic stress granules: the ins and outs of translation. Mol. Cell. 36, 932-941. doi: 10.1016/j.molcel.2009.11.020
39. Bugiani, O. (2007). The many ways to frontotemporal degeneration and beyond. Neurol. Sci. 28, 241-244. doi: 10.1007/s10072-007-0829-6
40. Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., et al. (1999). Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667-677. doi: 10.1097/00005072-199906000-00011
41. Buratti, E., and Baralle, F. E. (2001). Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337-36343. doi: 10.1074/jbc.M104236200
42. Buratti, E., and Baralle, F. E. (2010). The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 7, 420-429. doi: 10.4161/rna.7.4.12205
43. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y. M., and Baralle, F. E. (2005). TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572-37584. doi: 10.1074/jbc.M505557200
44. Buratti, E., De Conti, L., Stuani, C., Romano, M., Baralle, M., and Baralle, F. (2010). Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 277, 2268-2281. doi: 10.1111/j.1742-4658.2010.07643.x
45. Butler, G. S., Dean, R. A., Tam, E. M., and Overall, C. M. (2008). Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol. Cell. Biol. 28, 4896-4914. doi: 10.1128/MCB.01775-07
46. Cannon, A., Baker, M., Boeve, B., Josephs, K., Knopman, D., Petersen, R., et al. (2006). CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci. Lett. 398, 83-84. doi: 10.1016/j.neulet.2005.12.056
47. Carlton, J. G., and Martin-Serrano, J. (2007). Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316, 1908-1912. doi: 10.1126/science.1143422
48. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., et al. (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369. doi: 10.1016/j.cell.2011.09.028
49. Chai, X., Dage, J. L., and Citron, M. (2012). Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol. Dis. 48, 356-366. doi: 10.1016/j.nbd.2012.05.021
50. Chen, L., and Carmichael, G. (2009). Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol. Cell 35, 467-478. doi: 10.1016/j.molcel.2009.06.027
51. Chen-Plotkin, A. S., Xiao, J., Geser, F., Martinez-Lage, M., Grossman, M., Unger, T., et al. (2010). Brain progranulin expression in GRN-associated frontotemporal lobar degeneration. Acta Neuropathol. 119, 111-122. doi: 10.1007/s00401-009-0576-2
52. Chiò, A., Calvo, A., Moglia, C., Restagno, G., Ossola, I., Brunetti, M., et al. (2010). Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch. Neurol. 67, 1002-1009. doi: 10.1001/archneurol.2010.173
53. Clark, M. B., Amaral, P. P., Schlesinger, F. J., Dinger, M. E., Taft, R. J., Rinn, J. L., et al. (2011). The reality of pervasive transcription. PLoS Biol. 9:e1000625; discussion e1001102. doi: 10.1371/journal.pbio.1000625
54. Clovis, Y. M., Enard, W., Marinaro, F., Huttner, W. B., and De Pietri Tonelli, D. (2012). Convergent repression of Foxp2 3′UTR by miR-9 and miR-132 in embryonic mouse neocortex: implications for radial migration of neurons. Development 139, 3332-3342. doi: 10.1242/dev.078063
55. Colombrita, C., Onesto, E., Megiorni, F., Pizzuti, A., Baralle, F. E., Buratti, E., et al. (2012). TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 287, 15635-15647. doi: 10.1074/jbc.M111.333450
56. Colombrita, C., Onesto, E., Tiloca, C., Ticozzi, N., Silani, V., and Ratti, A. (2011). RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis. Arch. Ital. Biol. 149, 83-99. doi: 10.4449/aib.v149i1.1261
57. Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., et al. (2009). TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051-1061. doi: 10.1111/j.1471-4159.2009.06383.x
58. Cooper, T. A., Wan, L., and Dreyfuss, G. (2009). RNA and disease. Cell 136, 777-793. doi: 10.1016/j.cell.2009.02.011
59. Coppola, G., Karydas, A., Rademakers, R., Wang, Q., Baker, M., Hutton, M., et al. (2008). Gene expression study on peripheral blood identifies progranulin mutations. Ann. Neurol. 64, 92-96. doi: 10.1002/ana.21397
60. Corrado, L., Ratti, A., Gellera, C., Buratti, E., Castellotti, B., Carlomagno, Y., et al. (2009). High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum. Mutat. 30, 688-694. doi: 10.1002/humu.20950
61. Couchie, D., Mavilia, C., Georgieff, I. S., Liem, R. K., Shelanski, M. L., and Nunez, J. (1992). Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl. Acad. Sci. U.S.A. 89, 4378-4381. doi: 10.1073/pnas.89.10.4378
62. Cox, L. E., Ferraiuolo, L., Goodall, E. F., Heath, P. R., Higginbottom, A., Mortiboys, H., et al. (2010). Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5:e9872. doi: 10.1371/journal.pone.0009872
63. Craig, A., Graf, E., and Linhoff, M. (2006). How to build a central synapse: clues from cell culture. Trends Neurosci. 29, 8-20. doi: 10.1016/j.tins.2005.11.002
64. Cruts, M., Gijselinck, I., Van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., et al. (2006). Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924. doi: 10.1038/nature05017
65. Cruts, M., Theuns, J., and Van Broeckhoven, C. (2012). Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 33, 1340-1344. doi: 10.1002/humu.22117
66. Cruts, M., and Van Broeckhoven, C. (2008). Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet. 24, 186-194. doi: 10.1016/j.tig.2008.01.004
67. Custer, S. K., Neumann, M., Lu, H., Wright, A. C., and Taylor, J. P. (2010). Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 19, 1741-1755. doi: 10.1093/hmg/ddq050
68. D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V. M., Bird, T. D., et al. (1999). Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. U.S.A. 96, 5598-5603. doi: 10.1073/pnas.96.10.5598
69. Da Cruz, S., and Cleveland, D. W. (2011). Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 21, 904-919. doi: 10.1016/j.conb.2011.05.029
70. Dai, R. M., and Li, C. C. (2001). Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 3, 740-744. doi: 10.1038/35087056
71. Daniel, R., Daniels, E., He, Z., and Bateman, A. (2003). Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev. Dyn. 227, 593-599. doi: 10.1002/dvdy.10341
72. Daniel, R., He, Z., Carmichael, K. P., Halper, J., and Bateman, A. (2000). Cellular localization of gene expression for progranulin. J. Histochem. Cytochem. 48, 999-1009. doi: 10.1177/002215540004800713
73. De Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., et al. (2012). Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697. doi: 10.1016/j.neuron.2011.11.033
74. DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256. doi: 10.1016/j.neuron.2011.09.011
75. DeLaBarre, B., Christianson, J. C., Kopito, R. R., and Brunger, A. T. (2006). Central pore residues mediate the p97/VCP activity required for ERAD. Mol. Cell 22, 451-462. doi: 10.1016/j.molcel.2006.03.036
76. Deng, H.-X., Zhai, H., Bigio, E. H., Yan, J., Fecto, F., Ajroud, K., et al. (2010). FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739-748. doi: 10.1002/ana.22051
77. Díaz-Cueto, L., Stein, P., Jacobs, A., Schultz, R. M., and Gerton, G. L. (2000). Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev. Biol. 217, 406-418. doi: 10.1006/dbio.1999.9564
78. Di Carlo, V., Grossi, E., Laneve, P., Morlando, M., Dini Modigliani, S., Ballarino, M., et al. (2013). TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol. Neurobiol. 48, 952-963. doi: 10.1007/s12035-013-8564-x
79. Dickson, D. W. (1997). Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann. Neurol. 42, 541-544. doi: 10.1002/ana.410420403
80. Dickson, D. W. (2008). TDP-43 immunoreactivity in neurodegenerative disorders: disease versus mechanism specificity. Acta Neuropathol. 115, 147-149. doi: 10.1007/s00401-007-0323-5
81. Dickson, J. R., Kruse, C., Montagna, D. R., Finsen, B., and Wolfe, M. S. (2013). Alternative polyadenylation and miR-34 family members regulate tau expression. J. Neurochem. 127, 739-749. doi: 10.1111/jnc.12437
82. Dini Modigliani, S., Morlando, M., Errichelli, L., Sabatelli, M., and Bozzoni, I. (2014). An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA-FUS regulatory circuitry. Nat. Commun. 5:4335. doi: 10.1038/ncomms5335
83. Djamshidian, A., Schaefer, J., Haubenberger, D., Stogmann, E., Zimprich, F., Auff, E., et al. (2009). A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia. Muscle Nerve 39, 389-391. doi: 10.1002/mus.21225
84. Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 29, 2841-2857. doi: 10.1038/emboj.2010.143
85. Eddy, J., and Maizels, N. (2008). Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes. Nucleic Acids Res. 36, 1321-1333. doi: 10.1093/nar/gkm1138
86. Elia, N., and Sougrat, R. (2011). Dynamics of endosomal sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in abscission. Proc Natl Acad Sci U.S.A. 108, 4846-4851. doi: 10.1073/pnas.1102714108
87. Erickson, S. L., and Lykke-Andersen, J. (2011). Cytoplasmic mRNP granules at a glance. J. Cell Sci. 1, 293-297. doi: 10.1242/jcs.072140
88. Fan, Z., Chen, X., and Chen, R. (2014). Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression. Genomics 103, 76-82. doi: 10.1016/j.ygeno.2013.06.006
89. Farg, M. A., Sundaramoorthy, V., Sultana, M. J., Yang, S., Atkinson, R. A. K., Levina, V., et al. (2014). C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 23, 3579-3595. doi: 10.1093/hmg/ddu068
90. Feng, J., Bi, C., Clark, B. S., Mady, R., Shah, P., and Kohtz, J. D. (2006). The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 20, 1470-1484. doi: 10.1101/gad.1416106
91. Ferrari, R., Kapogiannis, D., Huey, E. D., Grafman, J., Hardy, J., and Momeni, P. (2010). Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 24, 397-401. doi: 10.1097/WAD.0b013e3181df20c7
92. Finch, N., Baker, M., Crook, R., Swanson, K., Kuntz, K., Surtees, R., et al. (2009). Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132, 583-591. doi: 10.1093/brain/awn352
93. Fox, A. H., and Lamond, A. I. (2010). Paraspeckles. Cold Spring Harb. Perspect. Biol. 2:a000687. doi: 10.1101/cshperspect.a000687
94. Fratta, P., Mizielinska, S., Nicoll, A. J., Zloh, M., Fisher, E. M. C., Parkinson, G., et al. (2012). C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2:1016. doi: 10.1038/srep01016
95. Freibaum, B. D., Chitta, R., High, A. A., and Taylor, J. P. (2011). Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 9, 1104-1120. doi: 10.1021/pr901076y
96. Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., et al. (2005). The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 15, 587-593. doi: 10.1016/j.cub.2005.01.058
97. Fujii, R., and Takumi, T. (2005). TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118, 5755-5765. doi: 10.1242/jcs.02692
98. Gabryelewicz, T., Masellis, M., Berdynski, M., Bilbao, J. M., Rogaeva, E., St George-Hyslop, P., et al. (2010). Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN). J. Alzheimer Dis. 22, 1123-1133. doi: 10.3233/JAD-2010-101413
99. Gallo, J.-M., Jin, P., Thornton, C. A., Lin, H., Robertson, J., D'Souza, I., et al. (2005). The role of RNA and RNA processing in neurodegeneration. J. Neurosci. 25, 10372-10375. doi: 10.1523/JNEUROSCI.3453-05.2005
100. Garzon, R., Marcucci, G., and Croce, C. (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9, 775-789. doi: 10.1038/nrd3179
101. Gass, J., Cannon, A., Mackenzie, I. R., Boeve, B., Baker, M., Adamson, J., et al. (2006). Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 15, 2988-3001. doi: 10.1093/hmg/ddl241
102. Gendron, T. F., Bieniek, K. F., Zhang, Y.-J., Jansen-West, K., Ash, P. E., Caulfield, T., et al. (2013). Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829-844. doi: 10.1007/s00401-013-1192-8
103. Ghanim, M., Guillot-Noel, L., Pasquier, F., Jornea, L., Deramecourt, V., Dubois, B., et al. (2010). CHMP2B mutations are rare in French families with frontotemporal lobar degeneration. J. Neurol. 257, 2032-2036. doi: 10.1007/s00415-010-5655-8
104. Ghazi-Noori, S., Froud, K. E., Mizielinska, S., Powell, C., Smidak, M., Fernandez de Marco, M., et al. (2012). Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 135, 819-832 doi: 10.1093/brain/aws006
105. Ghildiyal, M., and Zamore, P. D. (2009). Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10, 94-108. doi: 10.1038/nrg2504
106. Giaccone, G., Rossi, G., Di Fede, G., Marcon, G., Farina, L., Sacco, L., et al. (2004). Familial frontotemporal dementia is associated with the novel tau mutation T427M. Neurobiol. Aging 25, 449-450. doi: 10.1016/S0197-4580(04)81481-7
107. Gijselinck, I., Van der Zee, J., Engelborghs, S., Goossens, D., Peeters, K., Mattheijssens, M., et al. (2008). Progranulin locus deletion in frontotemporal dementia. Hum. Mutat. 29, 53-58 doi: 10.1002/humu.20651
108. Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., et al. (2012). A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 11, 54-65. doi: 10.1016/S1474-4422(11)70261-7
109. Goedert, M., and Jakes, R. (2005). Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta. 1739, 240-250. doi: 10.1016/j.bbadis.2004.08.007
110. Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., et al. (2001). Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23-34 doi: 10.1016/S0092-8674(01)00431-7
111. Grover, A., England, E., Baker, M., Sahara, N., Adamson, J., Granger, B., et al. (2003). A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy. Exp. Neurol. 184, 131-140. doi: 10.1016/S0014-4886(03)00393-5
112. Grover, A., Houlden, H., Baker, M., Adamson, J., Lewis, J., Prihar, G., et al. (1999). J. Biol. Chem. 274, 15134-15143. doi: 10.1074/jbc.274.21.15134
113. Guinto, J. B., Ritson, G. P., Taylor, J. P., and Forman, M. S. (2007). Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Acta Neuropathol. 114, 55-61. doi: 10.1007/s00401-007-0224-7
114. Guo, A., Tapia, L., Bamji, S. X., Cynader, M. S., and Jia, W. (2010). Progranulin deficiency leads to enhanced cell vulnerability and TDP-43 translocation in primary neuronal cultures. Brain Res. 1366, 1-8. doi: 10.1016/j.brainres.2010.09.099
115. Gutierrez, M. G., Munafo, D. B., Beron, W., and Colombo, M. I. (2004). Rab7 is requie for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 117(Pt 13), 2687-2697. doi: 10.1242/jcs.01114
116. Guyant-Maréchal, L., Laquerrière, A., Duyckaerts, C., Dumanchin, C., Bou, J., Dugny, F., et al. (2006). Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 67, 644-651. doi: 10.1212/01.wnl.0000225184.14578.d3
117. Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., et al. (2014). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195-200. doi: 10.1038/nature13124
118. Haubenberger, D., Bittner, R. E., Rauch-Shorny, S., Zimprich, F., Mannhalter, C., Wagner, L., et al. (2005). Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology 65, 1304-1305 doi: 10.1212/01.wnl.0000180407.15369.92
119. Hayashi, S., Toyoshima, Y., Hasegawa, M., Umeda, Y., Wakabayashi, K., Tokiguchi, S., et al. (2002). Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525-530. doi: 10.1002/ana.10163
120. Hayashi, Y. K. (2013). Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia. Rinsho Shinkeigaku 53, 947-950. doi: 10.5692/clinicalneurol.53.947
121. He, Z., and Bateman, A. (1999). Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res. 3222-3229.
122. He, Z., and Bateman, A. (2003). Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. (Berl). 81, 600-612. doi: 10.1007/s00109-003-0474-3
123. He, Z., Ong, C. H. P., Halper, J., and Bateman, A. (2003). Progranulin is a mediator of the wound response. Nat. Med. 9, 225-229. doi: 10.1038/nm816
124. Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-1520. doi: 10.1073/pnas.0710263105
125. Hermeking, H. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ. 2, 193-199. doi: 10.1038/cdd.2009.56
126. Hirabayashi, M., Inoue, K., Tanaka, K., Nakadate, K., Ohsawa, Y., Kamei, Y., et al. (2001). VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 8, 977-984. doi: 10.1038/sj.cdd.4400907
127. Hoell, J. I., Larsson, E., Runge, S., Nusbaum, J. D., Duggimpudi, S., Farazi, T., et al. (2011). RNA targets of wild-type and mutant FET family proteins. Nat. Struct. Mol. Biol. 18, 1428-1431. doi: 10.1038/nsmb.2163
128. Hoque, M., Mathews, M. B., and Pe'ery, T. (2010). Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters. J. Cell. Physiol. 223, 224-233. doi: 10.1002/jcp.22031
129. Hoque, M., Young, T., and Lee, C. (2003). The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Cell. Biol. 23, 1688-1702.
130. Huey, E. D., Ferrari, R., Moreno, J. H., Jensen, C., Morris, C. M., Potocnik, F., et al. (2012). FUS and TDP43 genetic variability in FTD and CBS. Neurobiol. Aging 33, 1016.e9-1016.e17. doi: 10.1016/j.neurobiolaging.2011.08.004
131. Huey, E. D., Grafman, J., Wassermann, E. M., Pietrini, P., Tierney, M. C., Ghetti, B., et al. (2006). Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann. Neurol. 60, 374-380. doi: 10.1002/ana.20969
132. Huntzinger, E., and Izaurralde, E. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110. doi: 10.1038/nrg2936
133. Huppert, J. L., Bugaut, A., Kumari, S., and Balasubramanian, S. (2008). G-quadruplexes: the beginning and end of UTRs. Nucleic Acids Res. 36, 6260-6268. doi: 10.1093/nar/gkn511
134. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705. doi: 10.1038/31508
135. Hutvagner, G., McLachlan, J., Pasquinelli, A. E., Balint, E., Tuschl, T., and Zamore, P. D. (2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838. doi: 10.1126/science.1062961
136. Iba, M., Guo, J. L., Mcbride, J. D., Zhang, B., Trojanowski, J. Q., and Lee, V. M. (2013). Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like Tauopathy J. Neurosci. 33, 1024-1037. doi: 10.1523/JNEUROSCI.2642-12.2013
137. Iijima, M., Tabira, T., Poorkaj, P., Schellenberg, G. D., Trojanowski, J. Q., Lee, V. M., et al. (1999). A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 10, 497-501. doi: 10.1097/00001756-199902250-00010
138. Iko, Y., Kodama, T. S., Kasai, N., Oyama, T., Morita, E. H., Muto, T., et al. (2004). Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 279, 44834-44840. doi: 10.1074/jbc.M408552200
139. Iovino, M., Pfisterer, U., Holton, J. L., Lashley, T., Swingler, R. J., Calo, L., et al. (2014). The novel MAPT mutation K,98E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons. Acta Neuropathol. 127, 283-295. doi: 10.1007/s00401-013-1219-1
140. Iseki, E., Matsumura, T., Marui, W., Hino, H., Odawara, T., Sugiyama, N., et al. (2001). Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells. Acta Neuropathol. 102, 285-292.
141. Ishigaki, S., Hishikawa, N., Niwa, J., Iemura, S., Natsume, T., Hori, S., et al. (2004). Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J. Biol. Chem. 279, 51376-51385. doi: 10.1074/jbc.M406683200
142. Ishigaki, S., Masuda, A., Fujioka, Y., Iguchi, Y., Katsuno, M., Shibata, A., et al. (2012). Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci. Rep. 2, 529. doi: 10.1038/srep00529
143. Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H., and Suzuki, N. (2011). Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann. Neurol. 69, 152-162. doi: 10.1002/ana.22246
144. Iyer, A., Lapointe, N. E., Zielke, K., Berdynski, M., Guzman, E., Barczak, A., et al. (2013). A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function. PLoS ONE 8:e76409. doi: 10.1371/journal.pone.0076409
145. Jacquin, A., Rouaud, O., Soichot, P., Bejot, Y., Dygai-Cochet, I., Sarazin, M., et al. (2013). Psychiatric presentation of frontotemporal dementia associated with inclusion body myopathy due to the VCP mutation (R155H) in a French family. Case Rep. Neurol. 5, 187-194. doi: 10.1159/000356481
146. Janssens, J., and Van Broeckhoven, C. (2013). Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum. Mol. Genet. 22, R77-R87. doi: 10.1093/hmg/ddt349
147. Jiao, J., Herl, L. D., Farese, R. V., and Gao, F.-B. (2010). MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia. PLoS ONE 5:e10551. doi: 10.1371/journal.pone.0010551
148. Johnson, J. O., Mandrioli, J., Benatar, M., Van Deerlin, V. M., Trojanowski, J. Q., Mora, G., et al. (2010). Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857-864. doi: 10.1016/j.neuron.2010.11.036
149. Johnson, J. O., Pioro, E. P., Boehringer, A., Chia, R., Feit, H., Renton, A. E., et al. (2014). Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664-666. doi: 10.1038/nn.3688
150. Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., et al. (2009). Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875-888. doi: 10.1083/jcb.200908115
151. Kabashi, E., Lin, L., Tradewell, M. L., Dion, P. A., Bercier, V., Bourgouin, P., et al. (2010). Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 19, 671-683. doi: 10.1093/hmg/ddp534
152. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Vande Velde, C., et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574. doi: 10.1038/ng.132
153. Kaleem, M., Zhao, A., Hamshere, M., and Myers, A. J. (2007). Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease. Neurodegener Dis. 4, 376-381. doi: 10.1159/000105158
154. Kara, E., Ling, H., Pittman, A. M., Shaw, K., de Silva, R., Simone, R., et al. (2012). The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol. Aging. 33, 2231.e7-2231.e14. doi: 10.1016/j.neurobiolaging.2012.04.006
155. Katzmann, D. J., Odorizzi, G., and Emr, S. D. (2002). Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3, 893-905. doi: 10.1038/nrm973
156. Kawahara, Y., and Mieda-Sato, A. (2012). TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. U.S.A. 109, 3347-3352. doi: 10.1073/pnas.1112427109
157. Kessenbrock, K., Fröhlich, L., Sixt, M., Lämmermann, T., Pfister, H., Bateman, A., et al. (2008). Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J. Clin. Invest. 118, 2438-2447. doi: 10.1172/JCI34694
158. Kikin, O., Zappala, Z., D'Antonio, L., and Bagga, P. S. (2008). GRSDB2 and GRS_UTRdb: databases of quadruplex forming G-rich sequences in pre-mRNAs and mRNAs. Nucleic Acids Res. 36, D141-D8.(Database issue):D141-8. doi: 10.1093/nar/gkm982
159. Kim, E.-J., Kwon, J. C., Park, K. H., Park, K.-W., Lee, J.-H., Choi, S. H., et al. (2014). Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia. Neurobiol. Aging. 35, 1213.e13-1213.e17. doi: 10.1016/j.neurobiolaging.2013.11.033
160. Kim, H.-J., Jeon, B. S., Yun, J. Y., Seong, M.-W., Park, S. S., and Lee, J.-Y. (2010a). Screening for MAPT and PGRN mutations in Korean patients with PSP/CBS/FTD. Parkinsonism Relat. Disord. 16, 305-306. doi: 10.1016/j.parkreldis.2010.01.004
161. Kim, S. H., Shanware, N. P., Bowler, M. J., and Tibbetts, R. S. (2010b). Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 285, 34097-34105. doi: 10.1074/jbc.M110.154831
162. Kim, V. N. (2004). MicroRNA precursors in motion: exportin-5 mediates their nuclear export. Trends Cell Biol. 14, 156-159. doi: 10.1016/j.tcb.2004.02.006
163. Kimonis, V. E., Mehta, S. G., Fulchiero, E. C., Thomasova, D., Boycott, K., Neilan, E. G., et al. (2008). Clinical studies in familial VCP myopathy associated with paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A. 28, 745-757. doi: 10.1002/ajmg.a.31862
164. King, I., Yartseva, V., Salas, D., Kumar, A., Heidersbach, A., Ando, D. M., et al. (2014). The RNA binding protein TDP-43 selectively disrupts MicroRNA-1/206 incorporation into the RNA-induced silencing complex. J. Biol. Chem. 289, 14263-14271. doi: 10.1074/jbc.M114.561902
165. Kobayashi, T., Ota, S., Tanaka, K., Ito, Y., Hasegawa, M., Umeda, Y., et al. (2003). Novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann. Neurol. 53, 133-137. doi: 10.1002/ana.10447
166. Kouri, N., Carlomagno, Y., Baker, M., Liesinger, A. M., Caselli, R. J., Wszolek, Z. K., et al. (2014). Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. 127, 271-282. doi: 10.1007/s00401-013-1193-7
167. Kovach, M. J., Waggoner, B., Leal, S. M., Gelber, D., Khardori, R., Levenstien, M., et al. (2001). Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 74, 458-475. doi: 10.1006/mgme.2001.3256
168. Kovacs, G. G., Murrell, J. R., Horvath, S., Haraszti, L., Majtenyi, K., Molnar, M. J., et al. (2009). TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 24, 1843-1847. doi: 10.1002/mds.22697
169. Kovacs, G. G., Pittman, A., Revesz, T., Luk, C., Lees, A., Kiss, E., et al. (2008). MAPT S305I mutation: implications for argyrophilic grain disease. Acta Neuropathol. 116, 103-118. doi: 10.1007/s00401-007-0322-6
170. Kumar, K. R., Needham, M., Mina, K., Davis, M., Brewer, J., Staples, C., et al. (2010). Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscul. Disord. 20, 330-334. doi: 10.1016/j.nmd.2010.03.002
171. Kwiatkowski, T. J., Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208. doi: 10.1126/science.1166066
172. Lagier-Tourenne, C., Baughn, M., Rigo, F., Sun, S., Liu, P., Li, H.-R., et al. (2013). Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A. 110, E4530-E4539. doi: 10.1073/pnas.1318835110
173. Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D. W. (2010). TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64. doi: 10.1093/hmg/ddq137
174. Lagier-Tourenne, C., Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C., et al. (2012). Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488-1497. doi: 10.1038/nn.3230
175. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. doi: 10.1038/35057062
176. Lanska, D. J., Currier, R. D., Cohen, M., Gambetti, P., Smith, E. E., Bebin, J., et al. (1994). Familial progressive subcortical gliosis. Neurology 44, 1633-1643. doi: 10.1212/WNL.44.9.1633
177. Law, W. J., Cann, K. L., and Hicks, G. G. (2006). TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief. Funct. Genomic. Proteomic. 5, 8-14. doi: 10.1093/bfgp/ell015
178. Le Ber, I., Van der Zee, J., Hannequin, D., Gijselinck, I., Campion, D., Puel, M., et al. (2007). Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum. Mutat. 28, 846-855. doi: 10.1002/humu.20520
179. Lee, E. B., Lee, V. M.-Y., and Trojanowski, J. Q. (2012). Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13, 38-50. doi: 10.1038/nrn3121
180. Lee, H.-G., Perry, G., Moreira, P. I., Garrett, M. R., Liu, Q., Zhu, X., et al. (2005). Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol. Med. 11, 164-169. doi: 10.1016/j.molmed.2005.02.008
181. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419. doi: 10.1038/nature01957
182. Lee, Y.-B., Chen, H.-J., Peres, J. N., Gomez-Deza, J., Attig, J., Stalekar, M., et al. (2013). Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 5, 1178-1186. doi: 10.1016/j.celrep.2013.10.049
183. Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S. H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060. doi: 10.1038/sj.emboj.7600385
184. Ling, S. C., Albuquerque, C. P., Han, J. S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H., et al. (2010). ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. U.S.A. 107, 13318-13323. doi: 10.1073/pnas.1008227107
185. Ling, S.-C., Polymenidou, M., and Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416-438. doi: 10.1016/j.neuron.2013.07.033
186. Liu, J., Carmell, M., and Rivas, F. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441. doi: 10.1126/science.1102513
187. Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., et al. (2012). Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7:e31302. doi: 10.1371/journal.pone.0031302
188. Lladó, A., Ezquerra, M., Sánchez-Valle, R., Rami, L., Tolosa, E., and Molinuevo, J. L. (2007). A novel MAPT mutation (P301T) associated with familial frontotemporal dementia. Eur. J. Neurol. 14, e9-e10. doi: 10.1111/j.1468-1331.2007.01763.x
189. Lopez de Munain, A., Alzualde, A., Gorostidi, A., Otaequi, D., Ruiz-Martinez, J., Indakoetxea, B., et al. (2008). Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol. Psychiatry 63, 946-952. doi: 10.1016/j.biopsych.2007.08.015
190. Luna-Muñoz, J., Harrington, C. R., Wischik, C. M., Flores-Rodriìguez, P., Avila, J., Zamudio, S. R., et al. (2013). "Phosphorylation of tau protein associated as a protective mechanism in the presence of toxic, C-terminally truncated tau in Alzheimer's disease," in Understanding Alzheimer's Disease, ed I. Zerr (InTech). doi: 10.5772/54228
191. Luquin, N., Yu, B., Saunderson, R. B., Trent, R. J., and Pamphlett, R. (2009). Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis. Neuromuscul Disord. 19, 696-700. doi: 10.1016/j.nmd.2009.07.005
192. Lynch, T., Sano, M., Marder, K. S., Bell, K. L., Foster, N. L., Defendini, R. F., et al. (1994). Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 44, 1878-1884. doi: 10.1212/WNL.44.10.1878
193. Mackenzie, I. R., Baker, M., Pickering-Brown, S., Hsiung, G.-Y. R., Lindholm, C., Dwosh, E., et al. (2006). The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129, 3081-3090. doi: 10.1093/brain/awl271
194. Mackenzie, I. R. A, Frick, P., and Neumann, M. (2014). The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 127, 347-357. doi: 10.1007/s00401-013-1232-4
195. Mackenzie, I. R., Rademakers, R., and Neumann, M. (2010). TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995-1007. doi: 10.1016/S1474-4422(10)70195-2
196. Marcon, G., Rossi, G., Giaccone, G., Giovagnoli, A. R., Piccoli, E., Zanini, S., et al. (2011). Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. J. Alzheimers Dis. 22, 1123-1133. doi: 10.3233/JAD-2011-110332
197. Martin-Serrano, J., and Neil, S. J. D. (2011). Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9, 519-531. doi: 10.1038/nrmicro2596
198. Medina, M., and Avila, J. (2014). The role of extracellular Tau in the spreading of neurofibrillary pathology. Front. Cell. Neurosci. 8:113. doi: 10.3389/fncel.2014.00113
199. Mehler, M. F., and Mattick, J. S. (2007). Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev. 87, 799-823. doi: 10.1152/physrev.00036.2006
200. Meissner, M., Lopato, S., Gotzmann, J., Sauermann, G., and Barta, A. (2003). Proto-oncoprotein tls/fus is associated to the nuclear matrix and complexed with splicing factors ptb, srm160, and sr proteins. Exp. Cell Res. 283, 184-195. doi: 10.1016/S0014-4827(02)00046-0
201. Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F., and Mattick, J. S. (2008). Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 105, 716-721. doi: 10.1073/pnas.0706729105
202. Metcalf, D., and Isaacs, A. M. (2010). The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes. Biochem. Soc. Trans. 38, 1469-1473. doi: 10.1042/BST0381469
203. Miyamoto, K., Kowalska, A., Hasegawa, M., Tabira, T., Takahashi, K., Araki, W., et al. (2001). Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the tau gene. Ann. Neurol. 50, 117-120. doi: 10.1002/ana.1083
204. Mizielinska, S., Lashley, T., Norona, F. E., Clayton, E. L., Ridler, C. E., Fratta, P., et al. (2013). C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 126, 845-857. doi: 10.1007/s00401-013-1200-z
205. Mizuno, Y., Hori, S., Kakizuka, A., and Okamoto, K. (2003). Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci. Lett. 343, 77-80. doi: 10.1016/S0304-3940(03)00280-5
206. Momeni, P., Rogaeva, E., Van Deerlin, V., Yuan, W., Grafman, J., Tierney, M., et al. (2006). Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener. Dis. 3, 129-133. doi: 10.1159/000094771
207. Mori, K., Lammich, S., Mackenzie, I. R., Forné, I., Zilow, S., Kretzschmar, H., et al. (2013a). hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 125, 413-423. doi: 10.1007/s00401-013-1088-7
208. Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., et al. (2013b). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science (New York, NY), 339, 1335-1338. doi: 10.1126/science.1232927
209. Morita, M., Al-Chalabi, A., Andersen, P. M., Hosler, B., Sapp, P., Englund, E., et al. (2006). A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66, 839-844. doi: 10.1212/01.wnl.0000200048.53766.b4
210. Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., et al. (2012). FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 31, 4502-4510. doi: 10.1038/emboj.2012.319
211. Mukherjee, O., Pastor, P., Cairns, N. J., Chakraverty, S., Kauve, J. S., Shears, S., et al. (2006). HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, taunegative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 60, 314-322. doi: 10.1002/ana.20963
212. Mukherjee, O., Wang, J., Gitcho, M., Chakraverty, S., Taylor-Reinwald, L., Shears, S., et al. (2008). Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum. Mutat. 29, 512-521. doi: 10.1002/humu.20681
213. Murrell, J. R., Spillantini, M. G., Zolo, P., Guazzelli, M., Smith, M. J., Hasegawa, M., et al. (1999). Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J. Neuropathol. Exp. Neurol. 58, 1207-1226. doi: 10.1097/00005072-199912000-00002
214. Naganuma, T., Nakagawa, S., Tanigawa, A., Sasaki, Y. F., Goshima, N., and Hirose, T. (2012). Alternative 3′-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 31, 4020-4034. doi: 10.1038/emboj.2012.251
215. Nakagawa, S., and Hirose, T. (2012). Paraspeckle nuclear bodies-useful uselessness? Cell. Mol. Life Sci. 69, 3027-3036. doi: 10.1007/s00018-012-0973-x
216. Nakagawa, S., Naganuma, T., Shioi, G., and Hirose, T. (2011). Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J. Cell Biol. 193, 31-39. doi: 10.1083/jcb.201011110
217. Nalbandian, A., Donkervoort, S., Dec, E., Badadani, M., Katheria, V., Rana, P., et al. (2011). The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 45, 522-531. doi: 10.1007/s12031-011-9627-y
218. Neumann, M., Diekmann, S., Bertsch, U., Vanmassenhove, B., Bogerts, B., and Kretzschmar, H. A. (2005). Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia. Neurogenetics 6, 91-95. doi: 10.1007/s10048-005-0210-y
219. Neumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., et al. (2009a). Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137-149. doi: 10.1007/s00401-008-0477-9
220. Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H. A., and Mackenzie, I. R. A. (2009b). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132(Pt 11), 2922-2931. doi: 10.1093/brain/awp214
221. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, NY) 314, 130-133. doi: 10.1126/science.1134108
222. Ng, S. Y., Lin, L., Soh, B. S., and Stanton, L. W. (2013). Long noncoding RNAs in development and disease of the central nervous system. Trends Genet. 29, 461-468. doi: 10.1016/j.tig.2013.03.002
223. Nishimoto, Y., Nakagawa, S., Hirose, T., Okano, H. J., Takao, M., Shibata, S., et al. (2013). The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain 6, 31. doi: 10.1186/1756-6606-6-31
224. Obita, T., Saksena, S., Ghazi-Tabatabai, S., Gill, D. J., Perisic, O., Emr, S. D., et al. (2007). Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4. Nature 449, 735-739. doi: 10.1038/nature06171
225. O'Rourke, J. R., and Swanson, M. S. (2009). Mechanisms of RNA-mediated disease. J. Biol. Chem. 284, 7419-7423. doi: 10.1074/jbc.R800025200
226. Ogaki, K., Li, Y., Takanashi, M., Ishikawa, K.-I., Kobayashi, T., Nonaka, T., et al. (2013). Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat. Disord. 19, 15-20. doi: 10.1016/j.parkreldis.2012.06.019
227. Okura, H., Yamashita, S., Ohama, T., Saga, A., Yamamoto-Kakuta, A., Hamada, Y., et al. (2010). HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. J. Atheroscler. Thromb. 17, 568-577. doi: 10.5551/jat.3921
228. Osborne, R. J., and Thornton, C., a. (2006). RNA-dominant diseases. Hum. Mol. Genet. 15 Spec No(2), R162-R9. doi: 10.1093/hmg/ddl181
229. Ou, S. H., Wu, F., Harrich, D., García-Martínez, L. F., and Gaynor, R. B. (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584-3596.
230. Pandit, S., Wang, D., and Fu, X.-D. (2008). Functional integration of transcriptional and RNA processing machineries. Curr. Opin. Cell Biol. 20, 260-265. doi: 10.1016/j.ceb.2008.03.001
231. Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. M., et al. (2006). ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67, 1074-1077. doi: 10.1212/01.wnl.0000231510.89311.8b
232. Pasquinelli, A. E. (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13, 271-282. doi: 10.1038/nrg3162
233. Pickering-Brown, S., Baker, M., Yen, S. H., Liu, W. K., Hasegawa, M., Cairns, N., et al. (2000). Pick's disease is associated with mutations in the tau gene. Ann. Neurol. 48, 859-867. doi: 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1
234. Pickering-Brown, S. M., Baker, M., Nonaka, T., Ikeda, K., Sharma, S., Mackenzie, J., et al. (2004). Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene. Brain 127(Pt. 6), 1415-1426. doi: 10.1093/brain/awh147
235. Plowman, G. D., Green, J. M., Neubauer, M. G., Buckley, S. D., Mcdonald, V. L., Todaro, G. J., et al. (1992). The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J. Biol. Chem. 267, 13073-13078.
236. Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., et al. (2011). Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459-468. doi: 10.1038/nn.2779
237. Poorkaj, P., Kas, A., D'Souza, I., Zhou, Y., Pham, Q., Stone, M., et al. (2001). A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm. Genome. 12, 700-712. doi: 10.1007/s00335-001-2044-8
238. Prasanth, K. V., Prasanth, S. G., Xuan, Z., Hearn, S., Freier, S. M., Bennett, C. F., et al. (2005). Regulating gene expression through RNA nuclear retention. Cell 123, 249-263. doi: 10.1016/j.cell.2005.08.033
239. Pye, V. E., Beuron, F., Keetch, C. A, McKeown, C., Robinson, C. V., Meyer, H. H., et al. (2007). Structural insights into the p97-Ufd1-Npl4 complex. Proc. Natl. Acad. Sci. U.S.A. 104, 467-472. doi: 10.1073/pnas.0603408104
240. Rademakers, R., Eriksen, J. L., Baker, M., Robinson, T., Ahmed, Z., Lincoln, S. J., et al. (2008). Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 17, 3631-3642. doi: 10.1093/hmg/ddn257
241. Reddy, K., Zamiri, B., Stanley, S. Y. R., Macgregor, R. B., and Pearson, C. E. (2013). The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 288, 9860-9866. doi: 10.1074/jbc.C113.452532
242. Reichelt, A. C., Rodgers, R. J., and Clapcote, S. J. (2012). The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology 62, 1519-1526. doi: 10.1016/j.neuropharm.2011.01.024
243. Renoux, A., and Todd, P. (2012). Neurodegeneration the RNA way. Prog. Neurobiol. 97, 173-189. doi: 10.1016/j.pneurobio.2011.10.006
244. Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268. doi: 10.1016/j.neuron.2011.09.010
245. Rizzini, C., Goedert, M., Hodges, J. R., Smith, M. J., Jakes, R., Hills, R., et al. (2000). Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J. Neuropathol. Exp. Neurol. 59, 990-1001.
246. Rizzu, P., van Swieten, J. C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., et al. (1999). High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Human Genet. 64, 414-421. doi: 10.1086/302256
247. Rossi, G., Bastone, A., Piccoli, E., Mazzoleni, G., Morbin, M., Uggetti, A., et al. (2012). New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization. Neurobiol. Aging 33, 834.e1-834.e6. doi: 10.1016/j.neurobiolaging.2011.08.008
248. Rossi, G., Bastone, A., Piccoli, E., Morbin, M., Mazzoleni, G., Fugnanesi, V., et al. (2014). Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features. Neurobiol. Aging 35, 408-417. doi: 10.1016/j.neurobiolaging.2013.08.004
249. Rosso, S. M., Donker, K. L., Baks, T., Joosse, M., de Koning, I., Pijnenburg, Y., et al. (2003). Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126, 2016-2022. doi: 10.1093/brain/awg204
250. Rosso, S. M., van Herpen, E., Deelen, W., Kamphorst, W., Severijnen, L. A., Willemsen, R., et al. (2002). A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease. Ann. Neurol. 51, 373-376. doi: 10.1002/ana.10140
251. Rouiller, I., DeLaBarre, B., May, A. P., Weis, W. I., Brunger, A. T., Milligan, R., et al. (2002). Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat. Struct. Biol. 9, 950-957 doi: 10.1038/nsb872
252. Rovelet-Lecrux, A., Deramecourt, V., Legallic, S., Maurage, C. A., Le Ber, I., Brice, A., et al. (2008). Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease. Neurobiol. Dis. 31, 41-45. doi: 10.1016/j.nbd.2008.03.004
253. Roxrud, I., Stenmark, H., and Malerød, L. (2010). ESCRT and Co. Biol. Cell, 102, 293-318. doi: 10.1042/BC20090161
254. Saman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Jackson, B., et al. (2012). Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 287, 3842-3849. doi: 10.1074/jbc.M111.277061
255. Sampathu, D. M., Neumann, M., Kwong, L. K., Chou, T. T., Micsenyi, M., Truax, A., et al. (2006). Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am. J. Pathol. 169, 1343-1352. doi: 10.2353/ajpath.2006.060438
256. Sareen, D., O'Rourke, J. G., Meera, P., Muhammad, A. K., Grant, S., Simpkinson, M., et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 5, 208ra149. doi: 10.1126/scitranslmed.3007529
257. Schenk, V. W. (1959). Re-examination of a family with Pick's disease. Ann. Hum. Genet. 23, 325-333. doi: 10.1111/j.1469-1809.1959.tb01476.x
258. Schmidt, O., and Teis, D. (2012). The ESCRT machinery. Curr. Biol. 22, R116-R120. doi: 10.1016/j.cub.2012.01.028
259. Schwartz, J. C., Ebmeier, C. C., Podell, E. R., Heimiller, J., Taatjes, D. J., and Cech, T. R. (2012). FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 26, 2690-2695. doi: 10.1101/gad.204602.112
260. Sephton, C. F., Cenik, C., Kucukural, A., Dammer, E. B., Cenik, B., Han, Y., et al. (2011). Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 286, 1204-1215. doi: 10.1074/jbc.M110.190884
261. Shan, X., Chiang, P.-M., Price, D. L., and Wong, P. C. (2010). Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 107, 16325-16330. doi: 10.1073/pnas.1003459107
262. Shankaran, S. S., Capell, A., Hruscha, A. T., Fellerer, K., Neumann, M., Schmid, B., et al. (2008). Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J. Biol. Chem. 283, 1744-1753. doi: 10.1074/jbc.M705115200
263. Shelkovnikova, T. A., Robinson, H. K., Troakes, C., Ninkina, N., and Buchman, V. L. (2014). Compromised paraspeckle formation as a pathogenic factor in FUSopathies. Hum. Mol. Genet. 23, 2298-2312. doi: 10.1093/hmg/ddt622
264. Shi, Z., Hayashi, Y. K., Mitsuhashi, S., Goto, K., Kaneda, D., Choi, Y.-C., et al. (2012). Characterization of the Asian myopathy patients with VCP mutations. Eur. J. Neurol. 19, 501-509. doi: 10.1111/j.1468-1331.2011.03575.x
265. Shim, S., Kimpler, L. A., and Hanson, P. I. (2007). Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 8, 1068-1079. doi: 10.1111/j.1600-0854.2007.00584.x
266. Simón, D., Garcia-Garcia, E., Royo, F., Falcon-Perez, J. M., and Avila, J. (2012). Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett. 586, 47-54. doi: 10.1016/j.febslet.2011.11.022
267. Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., et al. (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806-808. doi: 10.1038/ng1609
268. Skoglund, L., Matsui, T., Freeman, S. H., Wallin, A., Blom, E. S., Frosch, M. P., et al. (2011). Novel progranulin mutation detected in 2 patients with FTLD. Alzheimer Dis. Assoc. Disord. 25, 173-178. doi: 10.1097/WAD.0b013e3181fbc22c
269. Smith, B. N., Newhouse, S., Shatunov, A., Vance, C., Topp, S., Johnson, L., et al. (2012). The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur. J. Hum. Genet. 21, 102-108. doi: 10.1038/ejhg.2012.98
270. Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., et al. (2012). Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3), 693-708. doi: 10.1093/brain/awr355
271. Songsrirote, K., Li, Z., Ashford, D., Bateman, A., and Thomas-Oates, J. (2010). Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation. J. Proteomics 73, 1479-1490. doi: 10.1016/j.jprot.2010.02.013
272. Souquere, S., Beauclair, G., Harper, F., Fox, A., and Pierron, G. (2010). Highly ordered spatial organization of the structural long noncoding NEAT1 RNAs within paraspeckle nuclear bodies. Mol. Biol. Cell 21, 4020-4027. doi: 10.1091/mbc.E10-08-0690
273. Spillantini, M. G., and Goedert, M. (2000). Tau mutations in familial frontotemporal dementia. Brain 123, 857-859. doi: 10.1093/brain/123.5.857
274. Spillantini, M. G., and Goedert, M. (2013). Tau pathology and neurodegeneration. Lancet Neurol. 12, 609-622. doi: 10.1016/S1474-4422(13)70090-5
275. Spillantini, M. G., Goedert, M., Crowther, R. A., Murrell, J. R., Farlow, M. R., and Ghetti, B. (1997). Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. U.S.A. 94, 4113-4118. doi: 10.1073/pnas.94.8.4113
276. Spina, S., Murrell, J. R., Yoshida, H., Ghetti, B., Bermingham, N., Sweeney, B., et al. (2007). The novel Tau mutation G335S: clinical, neuropathological and molecular characterization. Acta Neuropathol. 113, 461-470. doi: 10.1007/s00401-006-0182-5
277. Spina, S., Murrell, J. R., Vidal, R., and Ghetti, B. (2008). Neuropathologic and genetic characterization of frontotemporal lobar degeneration with Ubiquitin- and/or Tdp-43-positive inclusions: a large series. Alzheimer's Dementia 4(Supp. 2), T431. doi: 10.1016/j.jalz.2008.05.1280
278. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. doi: 10.1126/science.1154584
279. Stallings, N. R., Puttaparthi, K., Luther, C. M., Burns, D. K., and Elliott, E. J. (2010). Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol. Dis. 40, 404-414. doi: 10.1016/j.nbd.2010.06.017
280. Stanford, P. M., Shepherd, C. E., Halliday, G. M., Brooks, W. S., Schofield, P. W., Brodaty, H., et al. (2003). Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126, 814-826 doi: 10.1093/brain/awg090
281. Stojkovic, T., Hammouda, E. H., Richard, P., Munain, A. L., De Ruiz-Martinez, J., Camaño, P., et al. (2009). Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia. Neuromuscul. Disord. 21, 316-323. doi: 10.1016/j.nmd.2009.02.012
282. Strong, M. J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., et al. (2007). TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35, 320-327. doi: 10.1016/j.mcn.2007.03.007
283. Suárez-Calvet, M., Dols-Icardo, O., Lladó, A., Sánchez-Valle, R., Hernández, I., Amer, G., et al. (2014). Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J. Neurol. Neurosurg. Psychiatr. 85, 684-691. doi: 10.1136/jnnp-2013-305972
284. Sunwoo, H., Dinger, M. E., Wilusz, J. E., Amaral, P. P., Mattick, J. S., and Spector, D. L. (2009). MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res. 19, 347-359. doi: 10.1101/gr.087775.108
285. Takamatsu, J., Kondo, A., Ikegami, K., Kimura, T., Fujii, H., Mitsuyama, Y., et al. (1998). Selective expression of Ser 199/202 phosphorylated tau in a case of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 9, 82-89. doi: 10.1159/000017028
286. Tan, A. Y., and Manley, J. L. (2009). The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 1, 82-92. doi: 10.1093/jmcb/mjp025
287. Tang, G., Tang, X., Mendu, V., Tang, X., Jia, X., Chen, Q.-J., et al. (2008). The art of microRNA: various strategies leading to gene silencing via an ancient pathway. Biochim. Biophys. Acta 1779, 655-662. doi: 10.1016/j.bbagrm.2008.06.006
288. Tang, X., Muniappan, L., Tang, G., and Özcan, S. (2009). Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA 15, 287-293. doi: 10.1261/rna.1211209
289. Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., et al. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357. doi: 10.1016/j.cell.2011.09.029
290. Thies, W., and Bleiler, L. (2011). 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 7, 208-244. doi: 10.1016/j.jalz.2011.02.004
291. Todd, P. K., and Paulson, H. L. (2010). RNA-mediated neurodegeneration in repeat expansion disorders. Ann. Neurol. 67, 291-300. doi: 10.1002/ana.21948
292. Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., et al. (2011). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452-458. doi: 10.1038/nn.2778
293. Urwin, H., Authier, A., Nielsen, J. E., Metcalf, D., Powell, C., Froud, K., et al. (2010). Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet. 19, 2228-2238. doi: 10.1093/hmg/ddq100
294. Usami, Y., Popov, S., Popova, E., Inoue, M., Weissenhorn, W., and G Göttlinger, H. (2009). The ESCRT pathway and HIV-1 budding. Biochem. Soc. Trans. 37(Pt 1), 181-184. doi: 10.1042/BST0370181
295. Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., and Parker, R. (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515-524. doi: 10.1101/gad.1399806
296. Van Blitterswijk, M., and Landers, J. E. (2010). RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 11, 275-290. doi: 10.1007/s10048-010-0239-4
297. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211. doi: 10.1126/science.1165942
298. Van Damme, P., Van Hoecke, A., Lambrechts, D., Vanacker, P., Bogaert, E., van Swieten, J., et al. (2008). Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J. Cell Biol. 181, 37-41. doi: 10.1083/jcb.200712039
299. Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., et al. (2008). TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409-416. doi: 10.1016/S1474-4422(08)70071-1
300. Van der Zee, J., Gijselinck, I., Dillen, L., Van Langenhove, T., Theuns, J., Engelborghs, S., et al. (2013). A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum. Mutat. 34, 363-373. doi: 10.1002/humu.22244
301. Van der Zee, J., Rademakers, R., Engelborghs, S., Gijselinck, I., Bogaerts, V., Vandenberghe, R., et al. (2006). A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129(Pt 4), 841-852. doi: 10.1093/brain/awl029
302. Van der Zee, J., Le Ber, I., Maurer-Stroh, S., Engelborghs, S., Gijselinck, I., Camuzat, A., et al. (2007). Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum. Mutat. 28, 416. doi: 10.1002/humu.9484
303. Van der Zee, J., Urwin, H., Engelborghs, S., Bruyland, M., Vandenberghe, R., Dermaut, B., et al. (2008). CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotypein vitro. Hum. Mol. Genet. 17, 313-322. doi: 10.1093/hmg/ddm309
304. Van der Zee, J., Van Langenhove, T., Kovacs, G. G., Dillen, L., Deschamps, W., Engelborghs, S., et al. (2014). Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 128, 397-410. doi: 10.1007/s00401-014-1298-7
305. Van Langenhove, T., van der Zee, J., Sleegers, K., Engelborghs, S., Vandenberghe, R., Gijselinck, I., et al. (2010). Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74, 366-371. doi: 10.1212/WNL.0b013e3181ccc732
306. Vesa, J., Su, H., Watts, G. D., Krause, S., Walter, M. C., Martin, B., et al. (2009). Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul. Disord. 19, 766-772. doi: 10.1016/j.nmd.2009.08.003
307. Wahid, F., Shehzad, A., Khan, T., and Kim, Y. Y. (2010). MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta 1803, 1231-1243. doi: 10.1016/j.bbamcr.2010.06.013
308. Wang, H.-Y., Wang, I.-F., Bose, J., and Shen, C.-K. J. (2004a). Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139. doi: 10.1016/S0888-7543(03)00214-3
309. Wang, Q., Song, C., and Li, C.-C. H. (2004b). Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J. Struct. Biol. 146, 44-57. doi: 10.1016/j.jsb.2003.11.014
310. Wang, T., Jiang, X., Chen, G., and Xu, J. (2015). Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiol. Aging 36, 527-535. doi: 10.1016/j.neurobiolaging.2014.07.044
311. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008b). The expression of microRNA miR-107 decreases arly in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223. doi: 10.1523/JNEUROSCI.5065-07.2008
312. Wang, W.-X., Wilfred, B. R., Madathil, S. K., Tang, G., Hu, Y., Dimayuga, J., et al. (2010). miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 177, 334-345. doi: 10.2353/ajpath.2010.091202
313. Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., et al. (2008a). Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130. doi: 10.1038/nature06992
314. Wang, Y. T., Kuo, P. H., Chiang, C. H., Liang, J. R., Chen, Y. R., Wang, S., et al. (2013). The Truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. J. Biol. Chem. 288, 9049-9057. doi: 10.1074/jbc.M112.438564
315. Watts, G. D. J., Thomasova, D., Ramdeen, S. K., Fulchiero, E. C., Mehta, S. G., Drachman, D. A., et al. (2007). Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 72, 420-426. doi: 10.1111/j.1399-0004.2007.00887.x
316. Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., et al. (2004). Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381. doi: 10.1038/ng1332
317. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 106, 18809-18814. doi: 10.1073/pnas.0908767106
318. Weihl, C. C., Dalal, S., Pestronk, A., and Hanson, P. I. (2006). Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 15, 189-199. doi: 10.1093/hmg/ddi426
319. Weihl, C. C., Miller, S. E., Hanson, P. I., and Pestronk, A. (2007). Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 16, 919-928. doi: 10.1093/hmg/ddm037
320. Whitley, P., Reaves, B. J., Hashimoto, M., Riley, A. M., Potter, B. V. L., and Holman, G. D. (2003). Identification of mammalian Vps24p as an effector of phosphatidylinositol 3,5-bisphosphate-dependent endosome compartmentalization. J. Biol. Chem. 278, 38786-38795. doi: 10.1074/jbc.M306864200
321. Wilhelm, B. T., Marguerat, S., Watt, S., Schubert, F., Wood, V., Goodhead, I., et al. (2008). Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution. Nature 453, 1239-1243. doi: 10.1038/nature07002
322. Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., et al. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U.S.A. 107, 3858-3863. doi: 10.1073/pnas.0912417107
323. Wolfe, M. S. (2012). The role of tau in neurodegenerative diseases and its potential as a therapeutic target. Scientifica 2012:796024. doi: 10.6064/2012/796024
324. Woodman, P. G. (2003). P97, a protein coping with multiple identities. J. Cell Sci. 116(Pt 21), 4283-4290. doi: 10.1242/jcs.00817
325. Wszolek, Z. K., Pfeiffer, R. F., Bhatt, M. H., Schelper, R. L., Cordes, M., Snow, B. J., et al. (1992). Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann. Neurol. 32, 312-320. doi: 10.1002/ana.410320303
326. Wu, H., Huang, M., Lu, M., Zhu, W., Shu, Y., Cao, P., et al. (2013a). Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother. Pharmacol. 71, 1159-1171. doi: 10.1007/s00280-013-2108-y
327. Wu, P., Zuo, X., Deng, H., Liu, X., Liu, L., and Ji, A. (2013b). Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res. Bull. 97, 69-80. doi: 10.1016/j.brainresbull.2013.06.001
328. Xiao, S., Sanelli, T., Dib, S., Sheps, D., Findlater, J., Bilbao, J., et al. (2011). RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS. Mol. Cell. Neurosci. 47, 167-180. doi: 10.1016/j.mcn.2011.02.013
329. Xu, Y. F., Gendron, T. F., Zhang, Y. J., Lin, W. L., D'Alton, S., Sheng, H., et al. (2010a). Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 30, 10851-10859. doi: 10.1523/JNEUROSCI.1630-10.2010
330. Xu, Y., Suzuki, Y., Ito, K., and Komiyama, M. (2010b). Telomeric repeat-containing RNA structure in living cells. Proc. Natl. Acad. Sci. U.S.A. 107, 14579-14584. doi: 10.1073/pnas.1001177107
331. Xu, Z., Poidevin, M., Li, X., and Li, Y. (2013). Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 110, 7778-7783. doi: 10.1073/pnas.1219643110
332. Yamada, S., Inoue, Y., Suga, A., and Iwazaki, M. (2011). Surgical risk of vessel injury: an unusual anatomical variant of the right medial basal segmental pulmonary artery. Gen. Thorac. Cardiovasc. Surg. 59, 301-303. doi: 10.1007/s11748-010-0655-2
333. Yan, J., Deng, H.-X., Siddique, N., Fecto, F., Chen, W., Yang, Y., et al. (2010). Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75, 807-814. doi: 10.1212/WNL.0b013e3181f07e0c
334. Yang, L., Embree, L. J., Tsai, S., and Hickstein, D. D. (1998). Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273, 27761-27764. doi: 10.1074/jbc.273.43.27761
335. Yin, F., Banerjee, R., Thomas, B., Zhou, P., Qian, L., Jia, T., et al. (2010). Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 207, 117-128. doi: 10.1084/jem.20091568
336. Zarranz, J. J., Ferrer, I., Lezcano, E., Forcadas, M. I., Eizaguirre, B., Atares, B., et al. (2005). A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578-1585. doi: 10.1212/01.WNL.0000160116.65034.12
337. Zhang, H., Wang, Q., and Kajino Kiichi, G. M. I. (2000). VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells. DNA Cell Biol. 19, 253-263. doi: 10.1089/10445490050021168
338. Zhang, Y.-J., Xu, Y., Dickey, C. A., Buratti, E., Baralle, F., Bailey, R., et al. (2007). Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534. doi: 10.1523/JNEUROSCI.3421-07.2007
339. Zheng, M., Liao, M., Cui, T., Tian, H., Fan, D. S., and Wan, Q. (2012). Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN. J. Cell Sci. 125(Pt 6), 1556-1567. doi: 10.1242/jcs.095729
340. Zhu, J., Nathan, C., Jin, W., Sim, D., Ashcroft, G. S., Wahl, S. M., et al. (2002). Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878. doi: 10.1016/S0092-8674(02)01141-8
341. Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110(Pt 1), 1741-1750.
342. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308. doi: 10.1038/emboj.2011.327
343. Zu, T., Liu, Y., and Bañez-Coronel, M. (2013). RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 110, E4968-E4977. doi: 10.1073/pnas.1315438110